The most studied SNPs of the P2X7 receptor result in loss or gain-of-function, and several studies associate these SNPs with disease development, symptomatology or disease worsening concerning AD, BD, MS, MDD, PD, and anxiety. This evidence concerns the gene P2RX7 and myeloid sarcoma.